Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Entera Bio Ltd., a foreign private issuer, covers the month of September 2019. The report, dated September 23, 2019, consists solely of a press release issued on that date, which is attached as Exhibit 99.1 and incorporated by reference. The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a vehicle to distribute a press release and does not contain a financial statement or quantitative financial data within the provided text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or specific operational changes are detailed in the cover page or signature section of this Form 6-K.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. While the filing incorporates a press release by reference, the content of that release is not included in the provided text, preventing a summary of management's forward-looking statements or risk factors.
Key Facts for Investor Verification
- Verify the content of the attached press release (Exhibit 99.1) for specific corporate updates, as the Form 6-K itself contains no operational details.
- Confirm the company's current cash position and runway by reviewing the most recent Form 20-F or 10-Q, as this filing lacks financial data.
- Check for any subsequent filings that may elaborate on the announcement made on September 23, 2019.